Health Secretary Robert F. Kennedy Jr. terminated Dr. John Wong and Dr. Esa Davis from the U.S. Preventive Services Task Force on May 11, citing a need for "clarity" in appointment processes. The letters stated their removal was effective immediately to prevent uncertainty in the panel's future work. Both leaders may reapply for positions.

The task force wields enormous influence over American healthcare by grading medical services that insurers must cover without cost-sharing under the Affordable Care Act. Its recommendations on mammograms, colonoscopies, and depression screenings directly affect which preventive care millions of patients receive annually. When the panel assigns an "A" or "B" grade, most insurance plans must cover those services fully.

Kennedy has systematically weakened the task force over the past year by postponing three consecutive meetings and failing to replace members whose terms expired in December. The committee's reduced output means fewer preventive services reach recommended coverage status, potentially increasing out-of-pocket costs for patients. Public health experts warn this interference undermines evidence-based medicine.

The disruption threatens a critical pipeline that connects scientific research to clinical practice, affecting pharmaceutical companies, medical device manufacturers, and insurers who rely on these evidence-based guidelines. Healthcare stocks could face volatility as investors assess potential delays in new coverage mandates.